Table 2.
FIGO stage | TNM staging | Tumor size | Lymph node involvement | Organ involvement | Distant metastases | MRI |
---|---|---|---|---|---|---|
1 |
T1a N0 M0 |
<2 cm | None | Vagina | None | Intact T2-hypointense vaginal wall |
T1b N0 M0 |
>2 cm | None | Vagina | None | ||
2 |
T2a N0 M0 |
<2 cm | None | Invades paravaginal tissue but not to pelvic sidewall | None | Disrupted T2-hypointense vaginal wall |
T2b N0 M0 |
>2 cm | None | Invades paravaginal tissue but not to pelvic sidewall | None | ||
3 |
T1, T2, or T3 N1 M0 OR T3 N0 M0 |
Any size Any size |
Inguinal or pelvic nodes None |
Invades pelvic sidewall, and/or lower vagina, and/or causing hydronephrosis Invades pelvic sidewall, and/or lower vagina, and/or causing hydronephrosis |
None None |
Abnormal T2-hyperintense pelvic musculature |
4A |
T4 Any N M0 |
Any size | Any N | Bladder, rectum, or extend beyond pelvis | None | Disrupted T2-hypointense bladder or rectal wall; abnormal enhancement of adjacent organs |
4B |
Any T Any N M1 |
Any size | Any N | Any T |
Yes Lung, liver, or bones |
Distant organ metastases (lungs and liver are most common) |